Christine Ring, Chief Legal Officer: Nurix Therapeutics NRIX Sell · Filed 25/04/30

Trade details

Type: Insider sale
Amount: $33,281
Shares · price: 2,894 sh · $11.50 a share
Held after: 37,318 sh
Stock: Nurix Therapeutics NRIX
Person: Christine RingChief Legal Officer
Trade date: 25/04/30
Filed: 25/04/30
Days to filing: 0 days

Sold 7.2% of holdings

Share of holding sold: 7.2%

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/31~25/05/30

Christine Ring's recent trades

Christine RingChief Legal Officer
Planned sale10b5-1 planNurix Therapeutics
Planned sale10b5-1 plan
Nurix Therapeutics
NRIX
$150.7K
5,787 sh
$150.7K
Filed 09/02
Traded 09/02
Christine RingChief Legal Officer
Planned sale10b5-1 planNurix Therapeutics
Planned sale10b5-1 plan
Nurix Therapeutics
NRIX
$385K
16,589 sh
$385K
Filed 08/03
Traded 08/03
Christine RingChief Legal Officer
Planned sale10b5-1 planNurix Therapeutics
Planned sale10b5-1 plan
Nurix Therapeutics
NRIX
$263.2K
11,008 sh
$263.2K
Filed 07/02
Traded 07/02
Christine RingChief Legal Officer
Sell10b5-1 planNurix Therapeutics
Sell10b5-1 plan
Nurix Therapeutics
NRIX
$580.4K
28,935 sh
$580.4K
Filed 06/25
Traded 06/25
Christine RingChief Legal Officer
Planned sale10b5-1 planNurix Therapeutics
Planned sale10b5-1 plan
Nurix Therapeutics
NRIX
$558.4K
28,935 sh
$558.4K
Filed 06/25
Traded 06/25